Developed by UNODC, WHO* and INCB
This module of the Toolkit has been developed in close collaboration with INCB and WHO and demonstrates interagency cooperation that is key to addressing the complex challenges posed by synthetic drugs.
Especially in times of a dual public health crisis, it is essential to ensure access to health care and essential medicines, while preventing their diversion. To address this issue, in August 2020 INCB, WHO and UNODC published a joint statement on access to internationally controlled medicines during COVID-19 pandemic.
Access to pain relief must be balanced with harm caused by the misuse of prescription pain medications, including opioids. This module of the Toolkit provides recommendations that address this issue and provides information on: